会社概要
- 正式社名: Chengdu Aupone Pharmaceutical Co.,Ltd.
- 登録国: China
- 住所: No. 990 Baicao Road, Tianfu New District, Chengdu, Sichuan, China • Sichuan
- 設立年: 2015
説明:
Chengdu Aupone Pharmaceutical Co., Ltd. supplies pharmaceutical intermediates to markets across Asia, North and South America, Western and Eastern Europe, Australasia, the Middle East and Africa. No further detailed company information is available.
事業活動
完成医薬品(製剤)
製造業者
原薬(API)
原薬メーカー
医薬用化学品
添加剤サプライヤー
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon
主要製品/サービス
- 医薬用化学品: Avanafil, Brivaracetam, Midodrine Hydrochloride, FERRIC MALTOL, Lumateperone tosylate, Iron Proteinsuccinylate, Urapidil Hydrochloride, Terbinafine Hydrochloride, Cenobamate, Opicapone, Fondaparinux sodium, Lemborexant, Taurolidine, Omadacycline Tosylate, Nemonoxacin Malate, Cariprazine Hydrochloride, Cetirizine Hydrochloride, Dexborneol, Iron Succinate, Landiolol hydrochloride, Mannatide, Meclofenoxate Hydrochloride, Minocycline hydrochloride, Revefenacin, Sertraline Hydrochloride, Tandospirone Citrate, Terbutaline sulfate
当社の製品・サービス
認証
FDA registration No
FDA
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す